NCT02376322View on ClinicalTrials.gov

Hypofractionated Radiotherapy (16/2) for the Palliation of Complicated Bone Metastases in Patients With KPS

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

July 30, 2016

Study Completion Date

July 30, 2016

Conditions
Bone Metastases
Interventions
RADIATION

Radiotherapy

Hypofractionated radiotherapy regimen, 16 Gy in 2 fractions in complicated bone metastases in patients with poor performance status

Trial Locations (4)

90000

ISCMPA, Porto Alegre

Unknown

ICESP, São Paulo

Sunnybrook Health Sciences Centre, Toronto

S. Maria Hospital, Terni

All Listed Sponsors
lead

Santa Casa de Porto Alegre

OTHER

NCT02376322 - Hypofractionated Radiotherapy (16/2) for the Palliation of Complicated Bone Metastases in Patients With KPS | Biotech Hunter | Biotech Hunter